TransMedics Group, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $605.5 | $441.5 | $241.6 | $93.5 | $31.4 |
| Operating income | $108.6 | $37.5 | -$28.7 | -$31.4 | -$39.4 |
| Net income | $190.3 | $35.5 | -$25.0 | -$36.2 | -$44.2 |
| Balance Sheet | |||||
| Total debt | — | — | — | $60.0 | $35.0 |
| Cash Flow Statement | |||||
| Free cash flow | $133.6 | -$80.9 | -$164.9 | -$57.7 | -$32.4 |
Shares outstanding 34.7M · Free float 93.1%
Annual filing data through FY ended December 31, 2025; float as of October 4, 2026.